Phil Tennant: ASCO is an incredible opportunity to connect with the oncology community

Phil Tennant, SVP, US Oncology BU Head at Astellas Pharma US, shared a post by Astellas Pharma, adding:            ,

“Every year, ASCO is an incredible opportunity to connect with the oncology community and share the latest in cancer research. This year was another exciting year for Astellas Oncology – we shared numerous research updates and officially launched our “Changing the Course Together” campaign, which underscores our collective dedication to redefining what’s possible through partnership and collaboration.

We also had our new head of US commercial Michael Petroutsas on board team Astellas at ASCO for the first time – watch more for his point of view on a day at the meeting. The team is already looking forward to next year! ”

Quoting Astellas Pharma’s post:

“Astellas Oncology is dedicated to changing the course of cancer, and we were excited to share our latest research at ASCO24.